KoBioLabs, Inc (KOSDAQ: 348150)
South Korea
· Delayed Price · Currency is KRW 6,270.00
+70.00 (1.13%)
Sep 12, 2024, 9:51 AM KST
KoBioLabs Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -11,096 | -13,853 | -21,921 | -15,382 | -55,072 | -44,067 | Upgrade
|
| Depreciation & Amortization | 1,995 | 1,515 | 908.06 | 232.72 | 209.89 | 144.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | 123.03 | - | 6.85 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -11.51 | -7.33 | - | - | Upgrade
|
| Stock-Based Compensation | 329.45 | 800.35 | 1,695 | 1,571 | 2,405 | 1,322 | Upgrade
|
| Other Operating Activities | -611.88 | -2,408 | 3,127 | -704.12 | 43,163 | 36,890 | Upgrade
|
| Change in Accounts Receivable | -4,489 | -1,266 | -702.54 | 2,478 | -2,570 | -107.25 | Upgrade
|
| Change in Inventory | -1,928 | -487.87 | -725.03 | -150.65 | 73.85 | 62.34 | Upgrade
|
| Change in Accounts Payable | 2.58 | - | - | - | -68.59 | 25.74 | Upgrade
|
| Change in Unearned Revenue | - | -114.78 | -512.29 | 361.64 | 206.07 | 64.82 | Upgrade
|
| Change in Other Net Operating Assets | 5,265 | 1,982 | 1,580 | -880.97 | -1,118 | -43.49 | Upgrade
|
| Operating Cash Flow | -10,410 | -13,832 | -16,556 | -12,481 | -12,771 | -5,709 | Upgrade
|
| Capital Expenditures | -8,516 | -15,133 | -14,683 | -5,512 | -124.98 | -56.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.22 | 0.81 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -428.32 | -81.81 | -39.07 | -150.81 | -233.73 | Upgrade
|
| Investment in Securities | 23,602 | 23,960 | -46,421 | -25,454 | 21,294 | -27,141 | Upgrade
|
| Other Investing Activities | 1,864 | -217.46 | -748.86 | -19.09 | -26.33 | -0.13 | Upgrade
|
| Investing Cash Flow | 16,949 | 8,192 | -61,814 | -31,154 | 20,992 | -27,432 | Upgrade
|
| Long-Term Debt Issued | - | 4,000 | 6,059 | 13,346 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -339.15 | -95.54 | -39.3 | -15.92 | -36.33 | Upgrade
|
| Net Debt Issued (Repaid) | -3,671 | 3,661 | 5,964 | 13,307 | -15.92 | -36.33 | Upgrade
|
| Issuance of Common Stock | 150.54 | 395.17 | 10,750 | 4,350 | 31,061 | 1,000 | Upgrade
|
| Other Financing Activities | -4.72 | -9.89 | 19,596 | -0 | 0 | - | Upgrade
|
| Financing Cash Flow | -3,525 | 4,046 | 36,310 | 55,741 | 31,045 | 30,605 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,115 | 1,208 | -199.67 | -40.36 | 82.39 | -1.05 | Upgrade
|
| Net Cash Flow | 4,129 | -386.23 | -42,260 | 12,066 | 39,348 | -2,537 | Upgrade
|
| Free Cash Flow | -18,926 | -28,966 | -31,239 | -17,993 | -12,896 | -5,765 | Upgrade
|
| Free Cash Flow Margin | -36.34% | -87.41% | -269.17% | -621.88% | -280.86% | -1000.04% | Upgrade
|
| Free Cash Flow Per Share | -997.47 | -1563.45 | -1859.89 | -1121.36 | -1202.99 | -816.16 | Upgrade
|
| Cash Interest Paid | 407.19 | 303.02 | 140.63 | 8.88 | 14.53 | - | Upgrade
|
| Cash Income Tax Paid | 126.62 | 249.35 | 239.81 | 180.4 | 56.09 | -1.26 | Upgrade
|
| Levered Free Cash Flow | -22,563 | -20,874 | -24,552 | -16,000 | -90,604 | 58,080 | Upgrade
|
| Unlevered Free Cash Flow | -21,827 | -19,916 | -23,501 | -15,904 | -90,162 | 58,566 | Upgrade
|
| Change in Net Working Capital | 6,964 | -5,160 | -2,210 | 859.15 | 83,254 | -62,565 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.